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Introduction

18
RNA-Seq is a powerful tool for studying gene expression, alternative splicing, and post-19 transcriptional regulation. Its utility has made it one of the most common experimental data types 20 stored in the Sequence Read Archive 1 and other related international archives 2 . However, public 21 archives store raw, unprocessed data. Drawing new conclusions from many raw RNA-Seq datasets 22 requires a level of computational power and expertise that is out of reach for most labs. Likewise, the 23 need to analyze this data from scratch leads to unnecessary duplications of effort across research 24 groups 3, 4 . To address this, we previously developed a bioinformatics pipeline (Rail-RNA 5, 6 ) and created 25 the recount2 7 resource and accompanying Snaptron 8 query engine. Together, these allow researchers to 26 query publicly available RNA-Seq data in a standardized and reproducible manner. In this work we focus 27 on the alternative splicing use case for RNA-Seq data. 28 Alternative splicing of pre-mRNA (RNA splicing) is a highly regulated process that generates 29 extensive transcriptomic and proteomic diversity across all cell types. RNA splicing is governed by both 30 cis-regulatory elements (specific sequences in the pre-mRNA that influence the strength of a splice site) 31 and trans-acting splicing factors (RNA-binding proteins that can act as either splicing enhancers or 32 repressors). RNA-Seq has accelerated our understanding of how alternative splicing networks are 33 coordinated, in part through the meta-analysis of RNA-Seq data gathered from many independent 34 experiments 9, 10 . Numerous algorithms for alternative splicing analysis have been developed [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] , 35 including several recent studies that propose useful models for studying complex splicing patterns in 36 RNA-Seq data 11, 17, 19 . However, there is a need for new methods that can summarize alternative splicing 37 across thousands of public datasets in a unified manner, without relying on prior transcript 38 annotation 27, 28 . Recount2 and Snaptron index gene expression and other metadata for over 70, 000 39 human RNA-Seq samples, but these databases currently lack alternative splicing summaries beyond the 40 level of junction counts. 41 Our work aims to make alternative splicing analysis of public RNA-Seq data accessible to the general 42 researcher by reducing computational barriers to entry. We have developed ASCOT (alternative splicing 43 catalog of the transcriptome), a resource that allows users to query alternative splicing and gene 44 expression across a wide range of cell types and tissues from mouse and human. ASCOT uses an 45 annotation-free method to quickly identify splice-variants in Snaptron 8 , a rapidly queryable database of 46 splice junction counts derived from the public archive. Given data from Snaptron, ASCOT performs a 47 rapid and computationally inexpensive "junction-walking" strategy to calculate the percent spliced-in 48 (PSI) ratio for a given exon, whereby inclusion and exclusion junctions are predicted using only counts 49 from a splice junction database (Fig. S1) . Although it is possible to capture more complex splicing 50 variation with nested decision trees, here we focus on four easily interpretable and binary splicing 51 patterns: cassette exons, alternative splice site exon groups, linked exons, and mutually exclusive exons. 52
This exon-centric approach can rapidly capture much of the alternative splicing in the transcriptome, 53 while simultaneously calculating each exon's PSI across thousands of Snaptron-indexed datasets. 54 We then used ASCOT to analyze datasets from a manually curated list of purified mouse cell types 55 32 , and over 50,000 other human RNA-59
Seq run accessions from the SRA as generated for the recount2 database. To demonstrate the utility of 60 our work, we used ASCOT to characterize the cell type-specific splicing patterns of rod photoreceptors. 61
The vertebrate nervous system derives much of its transcriptomic and proteomic diversity from 62 highly specific alternative splicing patterns that are not present elsewhere in the body 33 . Many neuronal 63 subtypes, such as rod photoreceptors, also exhibit alternative exons that are only detected in that 64 specific cell type 34 . Photoreceptors are cells within the retina that sense light and transduce this 65 information for the brain. These sensory neurons are unique in terms of morphology, metabolism, and 66 function-characteristics that may require specialized alternative exons [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Photoreceptor 67 degeneration is the main cause of hereditary blindness in the developed world. While some forms of 68 vision loss can be successfully managed with therapies such as angiogenesis inhibitors, prosthetic 69 devices, or tissue transplantation, few treatments exist for blindness that is directly caused by 70 photoreceptor degeneration. Understanding how photoreceptor-specific splicing patterns emerge may 71 facilitate development of cell-based regenerative strategies for treating photoreceptor dystrophies. 72
73
Results
74
We first tested if we could use ASCOT to identify neuron-specific splicing patterns (Fig. 1) . Publicly 75 available RNA-Seq datasets from mouse cell types across the body were manually curated from the SRA 76 and incorporated into ASCOT as a data compilation called MESA: mouse expression and splicing atlas. All 77 data is openly available at http://ascot.cs.jhu.edu/. These cell types were isolated by different research 78 groups using fluorescence-activated cell sorting (FACS) or affinity purification. As expected, we identified 79 many exons that were highly utilized (high PSI) in neurons but skipped by other cell types (Fig. 1A) . We 80 also identified exons exhibiting the opposite pattern, having high PSI across most cell types but low PSI 81 in neuronal cell types. Exons enriched in neurons could be further categorized based on their use in 82 muscles and/or pancreatic islet cells. Finally, an analysis of NRL-positive rod photoreceptors 44 , profiled 83 at several timepoints from postnatal day 2 (P2) to P28, revealed that rods utilize only a subset of pan-84 neuronal exons, and exclude many other exons that have high PSI across other neuronal subtypes (Fig.  85   3A) . This is consistent with the observation that rods do not express many common neuronal splicing 86 factors 34 ( Fig. S3 ). Next, we tested whether we could identify alternative exons utilized only by a single 87 neuronal cell type, despite near ubiquitous expression of the associated gene. We found many examples 88 of such exons (Fig. S4) . For instance, an exon in Sptan1 is only used by cochlear hair cells (Fig. 1B) , an 89 exon in Cnih1 is selectively used by excitatory pyramidal neurons (Fig. 1C) , and an exon in Exoc6b is 90 selectively used in oligodendrocytes (Fig. 1D) . 91
We next sought to cross-validate our mouse cell type results with RNA-Seq data from human tissue. 92
The Genotype-Tissue Expression (GTEx) project is a public archive of 9,662 human RNA-Seq samples 93 across 53 tissues, although it is missing retinal tissue. We therefore analyzed GTEx datasets, 94 supplemented with RNA-Seq data from peripheral retina 45 , and identified tissue-specific alternative 95 exons (Fig. S5) . We identified ~104 exons that are selectively utilized in human retina, compared to allother GTEx human tissues ( Fig. 2A-B) . In the mouse genome, we identified ~88 exons that were enriched 97 in rod photoreceptors, compared to all other mouse cell types in MESA. Cross referencing human retina-98 specific exons and mouse photoreceptor-specific exons revealed only 31 splicing events (found in 28 99 genes) that were syntenic between both species. These 28 genes generally fall under pathways of cilia 100 formation, neuronal connectivity and various metabolic pathways. Likewise, mutations in several genes 101 are linked to retinitis pigmentosa or intellectual disability, underscoring their functional importance (Fig.  102   2C ). Among the 31 rod-specific splicing events, 17/31 have been previously identified while 14/31 have 103 not been reported in the literature (Fig. S6) . Comparison of results between mouse and human is 104 important since there can be significant variation in splicing specificity between species. For example, an 105 exon in mouse Cep290 is only utilized by photoreceptors, but the syntenic exon in human CEP290 is 106 constitutively spliced across all human tissues. 107
To further test the sensitivity of our method, we incorporated single-cell RNA-Seq datasets 108 generated using full-length library strategies (e.g. SmartSeq, Fluidigm) into ASCOT as a compilation 109 called CellTower and analyzed the PSI tables for cell type-specific splicing patterns. Droplet-based 110 strategies that sequence short sequences from the polyA tail (e.g. DropSeq, 10x Genomics) are useful for 111 gene-level quantification, but are unable to capture most alternative splicing events. In contrast, single-112 cell protocols that capture sequences across the full transcript can analyze splicing, given sufficient read 113 depth. The Allen Brain Institute recently generated extremely high coverage single-cell datasets from 114 adult mouse primary visual cortex 32 and clustered cells into 49 types (19 glutamatergic, 23 GABAergic, 115 and 7 non-neuronal). Our analysis identified many alternative exons that showed not only differential 116 usage between glutamatergic, GABAergic, and non-neuronal cell types, but also high variation within 117 each broad grouping (Fig. S7A ). We were also able to identify mutually exclusive exons that varied 118 among cell types, including those previously analyzed 32 ( Fig. S7B ). Having validated our approach using 119 single-cell RNA-Seq data, we then analyzed a dataset containing both retinal progenitor cells and 120 immature postmitotic precursor cells 46 from embryonic days E14, E18 or P2 that were profiled using 121 Smart-Seq. We found that rod-specific exons in Atp1b2 and Ttc8 were detectable at low levels in early 122 photoreceptor precursors, but not in retinal progenitors or postmitotic precursors of other retinal cell 123 types (Fig. S7C) . Lastly, we confirmed that cell type-specific alternative exons in Sptan1, Cnih1 and 124 Exoc6b (Fig. 1B-D) exhibited the same specificity in CellTower (Fig. S7D) . 125
What are the splicing factors that mediate rod-specific splicing patterns identified in MESA (Fig. 3A) ? 126
Although rods do not express many of the RNA-binding proteins (RBPs) thought to be involved in 127 regulating alternative splicing in neurons (Fig. S3 ) 34 , they do show similar relative expression levels ofrepress many exons, and downregulation of Ptbp1 accompanied by an upregulation of Ptbp2 is an 130 important prerequisite for neuronal splicing [47] [48] [49] [50] [51] [52] [53] [54] . We hypothesized that certain RBPs, acting as splicing 131 enhancers, could be selectively expressed in rods to mediate rod-specific splicing. We defined a list of 132 putative splicing factors by identifying genes with RNA-binding domains, as determined by RBPDB 55 , in 133 the InterPro database. Overlapping rod-enriched genes with putative splicing factors revealed two top 134 candidates, Musashi RNA-binding protein 1 (Msi1) and Poly(rC)-binding protein 2 (Pcbp2), that were 135 expressed at much higher levels in rods relative to other cell types across the body. This is consistent 136 with previous work demonstrating that Msi1 promotes photoreceptor-specific splicing 34 , although no 137
studies have yet shown if Pcbp2 performs a similar function. We also considered the possibility that 138 knockdown of constitutive splicing factors could activate rod-specific exons. However, analysis of 1,159 139 datasets from the ENCODE shRNA-Seq project 30, 31 did not reveal any shRNA knockdown that could 140 activate rod-specific exons (Fig. 4A) . 141
To test whether MSI1 and PCBP2 overexpression was sufficient to activate rod-specific exons, we 142 transfected these proteins into HepG2 cells, a liver cancer cell line used by the ENCODE project. Initially, 143
we found that normal transfection of MSI1 or PCBP2 could not activate rod-specific exons (Fig. S8) . 144
However, given the extremely high expression of these factors in mature rods, we hypothesized that the 145 average expression levels achieved by transfection were not high enough to induce rod-specific splicing. 146
We therefore used FACS to isolate the most strongly GFP-positive MSI1/PCBP2-transfected HepG2 cells 147 (with or without simultaneous knockdown of PTBP1) to more accurately reflect the expression levels of 148 these splicing factors seen in mature rods. These robustly transfected cells had significant activation of 149 rod-specific exons (Fig. 4A) . Specifically, PCBP2 activated a single rod-specific exon in the 150 monocarboxylate transporter Basigin (BSG) independent of PTBP1 knockdown; BSG is necessary for 151 photoreceptor survival [39] [40] [41] . By contrast, high expression of MSI1 activated an extremely broad range of 152 exons and appears to strongly synergize with PTBP1 downregulation (Fig. 4A, Fig. S9 ). Not only are high 153 levels of MSI1 capable of activating rod-specific exons in HepG2 cells, we also observed activation of 154 neuronal/muscle enriched exons thought to be regulated by PTBP1 knockdown. Indeed, exon activation 155 by MSI1 alone was stronger than the effect of knockdown of PTBP1 alone, suggesting a more complex 156 interaction between MSI1 and PTBP1 (Fig. S9) . Interestingly, we also identified nonconserved exons that 157
were activated by MSI1, many of which are not found in any other human tissue (Fig. 4A) . These 158 nonconserved cryptic exons are likely incidentally activated by the extremely high expression of MSI1 inthe most robustly transfected cells. This contrasts with our previous work in which nonconserved cryptic 160 exons are activated as a result of knockdown of splicing factor repressors 47, 54, 56 . 161 MSI1 has been reported to selectively bind to RNA that contain multiple UAG sequences 34, [57] [58] [59] [60] [61] [62] [63] . A 162 motif analysis reveals that UAG clusters are significantly enriched at the proximal intron of the 5' splice 163 site (Fig. 4B) ; this pattern was consistent for both conserved and nonconserved exons. Of the 31 164 syntenic rod-specific exons, the majority are flanked by binding motifs for both PTBP1 and MSI1 (Fig.  165   S10 ). UAG motif frequencies were compared to a baseline of all protein coding exons (<400bp) in the 166 GENCODE v28 basic gene annotation and examples of conserved and nonconserved exons are visualized 167 in Figure 5A . 168
Finally, we wanted to test whether loss of Msi1 or Pcbp2 function would result in a reduction of rod-169 specific exon splicing. We electroporated mouse retinal explants with shRNA or dominant negative 170 versions of Msi1 and Pcbp2 (Fig. 5B ) and found that while reducing PCBP2 function did not affect splicing 171 of the rod-specific exon in Bsg, reducing Msi1 function with shRNA or a dominant negative protein 172 blocked rod-specific splicing (Fig. S11) . We confirmed that this result was specific to Msi1 by 173 electroporating shRNA targeting Msi2 (an Msi1 homolog), and found that Msi2 shRNA did not reduce 174 rod-specific splicing. We then analyzed the expression of a set of genes correlated with photoreceptor 175 differentiation 64 and found that Msi1 loss of function leads to expression patterns that resembled 176 immature P2-P4 photoreceptors (Fig. S11AA) . Overall, expression of dominant negative Msi1 mimics 177
Msi1 knockdown, but produces a somewhat weaker effect (Fig. 5B) . Interestingly, while most rod-178 specific exons are reduced after Msi1 knockdown, some rod-specific exons remain robustly incorporated 179 (e.g. Doc2b, Ppp3cc, Plekhb1). 180
181
Discussion
182
We have developed ASCOT, a resource that enables researchers to more easily perform cross-study 183 splicing and expression analyses of public RNA-Seq data. ASCOT rapidly calculates exon PSIs and 184 alternative splicing patterns using an annotation-free method that queries the junction-level summaries 185 of Snaptron. ASCOT's user interface and associated splicing/expression datasets are openly available at 186 http://ascot.cs.jhu.edu. Although there have been past efforts to summarize public RNA-Seq data 27, 28, 65 , 187
ASCOT represents the largest effort to date to make alternative splicing and gene expression summaries 188 of large datasets available to general researchers. This is possible because our method builds upon the 189 recount2 7 and Snaptron 8 resources, which summarize publicly archived datasets in a scalable manner 190 without relying on gene annotations.
Beyond scalability, ASCOT have several other advantages for analyzing cell type-specific alternative 192 splicing. First, dataset columns in splicing and expression summaries can be easily grouped and 193 regrouped depending on the researchers needs, a feature that is especially useful for analyzing single-194 cell data (Fig. S7) . For example, clustering neonatal inner ear cells 66 based on primary cell type confirms 195 that the exon in Sptan1 (Fig. 1B) 
identify many exons that are differentially utilized between brain and heart that were not detected in 201
Leafcutter's shiny app visualization, LeafViz (https://leafcutter.shinyapps.io/leafviz/) 11 ( Fig. S13) . Second, 202
ASCOT does not require transcript references to identify alternative splicing events, and is therefore 203 unbiased toward annotated or unannotated exons. We estimate that ~40-60% of mouse and ~10-30% of 204 human cassette exons identified by ASCOT are unannotated (Fig. S12) . Third, ASCOT can answer custom 205 queries that go beyond the datasets summarized in this study. For example, we queried rod-specific 206 exons across 50,062 public datasets in the SRA (SRAv2 Snaptron compilation) to estimate the frequency 207 of retinal datasets in the public archive (Fig. S14) . We found 37 datasets (0.07%) that had high PSI levels 208 of rod-specific exons, and confirmed that these datasets were indeed from human retina. Finally, ASCOT 209 is built upon Snaptron, which summarizes single-and paired-end RNA-Seq data of various read lengths. 210
By starting the analysis from a splice junction count table, ASCOT can analyze alternative splicing across 211 tens of thousands of archived RNA-Seq datasets without having to restart the analysis from raw reads. 212 ASCOT is currently limited by its inability to detect complex alternative splicing events that other 213 algorithms 11, 19 can identify. We intentionally targeted binary splicing decisions as they can be robustly 214 detected and have a straightforward biological interpretation. However, complex splicing can certainly 215 be modeled with nested decision trees that would still be compatible with a junction-walking strategy. 216
We believe that splice junction count tables contain sufficient information to build these splice models. 217 Also, ASCOT does not attempt to model biases that can distort junction counts, such as GC content or 218 secondary structure. We plan for future versions of ASCOT to model and mitigate these effects. 219
We used ASCOT to study tens of thousands of datasets from SRA, ENCODE, GTEx. Analyzing splicing 220 factor gene expression across various mouse cell types allowed us to identify MSI1 and PCBP2 as 221 candidates for inducing rod-specific splicing patterns, while the ENCODE shRNA-Seq data confirmed for 222 us that knockdown of constitutive splicing factors could not activate rod-specific exons. Taken together,these observations led to the hypothesis that manipulating certain splicing factors could lead to rod-like 224 splicing patterns. Only with this hypothesis in mind were we able to generate new data to conclude that 225 robust overexpression of PCBP2 and MSI1 combined with PTBP1 knockdown was able to activate rod-226 specific exons, even in a non-neuronal cell line such as HepG2. This study is emblematic of a larger shift 227 toward using public datasets, often pre-summarized or indexed, to generate hypotheses and narrow the 228 scientific question prior to designing experiments and generating new data. Resources such as ASCOT 229 can save researchers much time and effort, as well as create new avenues of research for smaller labs 230 with limited funding. 231
Together, our results suggest a model of photoreceptor splicing regulation (Fig. 5C ) whereby MSI1 232 and PTBP1 downregulation interact synergistically. MSI1 overexpression leads to the incorporation of 233 PTBP1-repressed exons, while PTBP1 downregulation increases MSI1's ability to activate rod-specific 234 exons (Fig. S9) . We have also identified that PCBP2 is another regulator of photoreceptor-specific 235 splicing. The rod-specific exon in BSG is essentially undetectable in all non-retinal tissues and PCBP2 236 overexpression increases the exon PSI to ~8% (PSI in photoreceptors is >80%). However, mouse retina 237 electroporation of shRNA and dominant negative constructs targeting PCBP2 did not reduce levels of the 238 rod-specific BSG exon, suggesting that PCBP2 overexpression can activate the exon in non-neuronal cells 239 but is not required to maintain splicing in mature photoreceptors. In contrast, knockdown of Msi1 in 240 electroporated mouse retina abolishes most of the rod-specific splicing events, leading to a delay in 241 photoreceptor maturation (Fig. S10a) . Although high levels of MSI1 are required for photoreceptor-242 specific splicing, our results indicate that MSI1 expression levels must still be titrated, since excessive 243 overexpression in HepG2 cells led to the incorporation of deleterious, nonconserved cryptic exons (Fig.  244   4A) . 245
These nonconserved exons reinforce the importance of obtaining human RNA-Seq data at the 246 resolution of individual cell types, as there can be significant differences in splicing between mouse and 247 human. With ASCOT, we identified 31 syntenic photoreceptor-specific splicing events. However, this 248 analysis is incomplete since isolated mouse photoreceptors were compared to human retina as opposed 249 to isolated human photoreceptors. More remains to be understood about splicing in the retina since 250 neighboring cell types, epigenetic states, and/or developmental timing may play a role in mediating 251 optimal photoreceptor splicing. Conditional knockout of Msi1 in the adult retina will help clarify these 252 results, as will single-cell sequencing of human retinal organoids. 253
ASCOT is part of a larger effort to make gene expression and alternative splicing data more 254 accessible to the general researcher 7, 8 . By reducing the initial barriers to data analysis, we hope to 255 accelerate cross-disciplinary work and foster unexpected discoveries. Dominant negative constructs were generated using an N-terminal truncated PCBP2 sequence (ΔKH1-301 PCBP2, aa125-365) and a C-terminal truncated MSI1 sequence (aa1-199). Sequences were cloned into 302 pCAGIG. Empty pCAGIG vector was used as a second control. 303
Generation of Snaptron compilations 304
Raw RNA-Seq fastq reads from all the input accessions were first analyzed using the Rail-RNA spliced 305 alignment program as described in previous publications 5, 6 . Rail-RNA outputs a few summaries for each 306 run accession, including a table of splice-junction evidence. In this table, each row is a splice junction 307 and each column is an individual run accession. The elements of the table give the number of times a 308 spliced alignment from an individual (column) spanned a junction (row). These summaries are then 309 composed and indexed using Tabix and SQLite, and all the associated metadata for the run accessions 310 are indexed using Lucene, to form a Snaptron compilation. A Snaptron compilation can be queried via 311 command line or via RESTful API queries. 312
ASCOT methods and software 313
Methods by ASCOT to detect alternative splicing are described in detail in Supplemental Figure 1 . All 314 scripts used to generate ASCOT are available on a GitHub repository at https://github.com/jpling/ascot. 315
The user interface, raw splicing and expression data tables, and bigwig tracks for visualization are 316 available at http://ascot.cs.jhu.edu. 317 (A) Mouse RNA-Seq datasets were manually curated from the SRA, covering a broad range of cell types and organs. Cell type datasets were generated from various independent labs using FACS or affinity isolation. To test our algorithm, we identified alternative exons that were differentially spliced between neuronal cell types and other cell types in the body and found that exons could be generally clustered by their inclusion or exclusion in rods, neurons, muscles, pancreas, or global non-neuronal (right columns). Each row is an individual exon, and exon utilization is measured by a percent spliced in (PSI) ratio as indicated by gradient legend (bottom). The overlap between neuronal exons and muscle cell types agrees with observations from our previous work on Ptbp1 and Ptbp2
47
, suggesting that these exons are at least partially activated by Ptbp1 downregulation. There is only partial overlap between rod exons and neuron-enriched exons, which is not unexpected since rods do not express many neuron-enriched splicing factors (Fig. S3). (B-D) Our splicing analysis method reliably identifies alternative exons that are unique to specific cell types. For example, an exon in Sptan1 is specifically enriched in cochlear hair cells, despite ubiquitous expression across all organs and cell types (B). Likewise, an exon in Cnih1 is specifically enriched in pyramidal neurons (C) and an exon in Exoc6b is selectively enriched in myelinating oligodendrocytes (D).
Figure 2. Splicing analysis of the GTEx database reveals retina-specific exons.
We cross-referenced our mouse splicing analysis with human RNA-Seq datasets generated by the GTEx consortium 29 . We also supplemented our analysis with datasets from peripheral retina 45 , since GTEx did not sequence retinal tissue. (A) Similar to our mouse splicing analysis, we find many exons that are brain-enriched and that some of these exons are also present in skeletal muscle and heart. We also find that some exons are utilized in the pituitary and testes, tissues that are not present in our mouse database. We do not find overlaps in exon usage with GTEx pancreas because these datasets are generated from whole pancreas instead of pancreatic islets or α & β-cells. Importantly, we can identify alternative exons that are only spliced in retina. (B) Bigwig visualizations of raw GTEx RNA-Seq data. An exon in MARK4 is present in retina, brain, and muscle. An exon in CLTB is present in retina and brain. Two exons, one in IMPDH1 and one in BSG, are only present in retina and not in other GTEx tissues. (C) Comparing rod-specific exons in mouse with retina-specific exons in human yields a set of 31 syntenic exons that are likely important for photoreceptor function. Genes with rod-specific exons can be clustered under a variety of pathways from cilia formation and neuronal signaling to metabolism and GPCR pathways (left). Mutations in several of these genes are also associated with either retinitis pigmentosa or intellectual disability (right). The Ptbp2/Ptbp1 ratio gradually increases in rods over development from P2 to P28. However, we also find that cochlear hair cell sensory neurons retain high levels of Ptbp1, suggesting that perhaps not all neurons switch from using Ptbp1 to Ptbp2. To identify the factors that might mediate the splicing of rodspecific exons, we cross referenced genes with expression patterns that were enriched in rods with a list of putative RBPs and identified Msi1 and Pcbp2 as potential candidates. Note that the expression of Msi2, a paralog to Msi1, does not show the same selectively high expression in rods. Figure 4 . Overexpression of MSI1 and PCBP2 in HepG2 cells activates rod-specific exons. We analyzed human ENCODE shRNA-Seq datasets 30, 31 to test whether knockdown of constitutive splicing factors activates rod-specific exons. We also sought to test whether overexpression of MSI1 and PCBP2 activates rod-specific exons in the liver cancer HepG2 cell line (used by the ENCODE consortium). (A) Rows represent alternative exons, grouped by conservation. Columns represent RNA-Seq datasets, grouped into three categories: 1. HepG2 control and overexpression datasets generated in our lab, 2. HepG2 shRNA-Seq datasets generated by the ENCODE consortium (only a subset of the full data representing well known splicing factors, full database of all shRNA-Seq datasets is available at http://ascot.cs.jhu.edu/data), 3. Various GTEx tissues 29 and peripheral retina 45 as reference data (retina, brain, and skeletal muscle are highlighted in red). No HepG2 shRNA knockdown datasets are capable of activating rod-specific exons but overexpression of MSI1 followed by FACS isolation of the top 1% expressing cells can successfully activate rod-specific exons. Unexpectedly, robust MSI1 overexpression can also activate neuronal-and muscle-enriched exons. These patterns can also be modestly detected in the PTBP1 shRNA knockdown ENCODE dataset, but MSI1 expression alone induces a greater level of activation. Furthermore, we overexpressed MSI1 with PTBP1 siRNA and found that this combination appeared to act synergistically in activating retina/brain/muscle exons and led to a general increase in rod-specific exon incorporation (Fig. S9) . Interestingly, we also find that MSI1 overexpression can activate a set of nonconserved exons that are not found in any other human tissue (B) Motif analysis of intronic sequences (+/-1000bp from 5' and 3'SS) and exonic sequences (+/-50bp from 5' and 3'SS) reveals that UAG motifs are enriched in a 200bp intronic window proximal to the 5'SS. UAG motifs are the consensus binding site for MSI1 57, 59, 60 . Repetitive CU/UC elements, the binding site for PTBP1, can also be found upstream of most rod-specific exons (Fig. S10) . GDAP1, MTRR) . Overexpression of PCBP2 activates the rod-specific exon in BSG, independent of PTBP1 knockdown. In contrast, MSI1 overexpression in combination with PTBP1 knockdown activates both rod-specific exons (IMPDH1, MAN2A2, PPP3CC) and pan-neuronal exons (TNRC6A). High levels of MSI1 overexpression can also activate cryptic nonconserved exons (RDX, GDAP1) that are not found elsewhere in the body. However, some of the nonconserved exons activated by MSI1 overexpression are not cryptic and can be found in photoreceptors (MTRR). (B) Electroporation of Msi1 shRNA in mouse retina abolishes nearly all rod-specific splicing (Atp1b2, Efr3a, Cask). However, some rod-specific exons (Doc2b) remain unaffected (Fig. S11 ). (C) Model for the regulation of photoreceptor-specific splicing. Increased expression of MSI1 and downregulation of PTBP1 act synergistically to activate rod-specific exons, while increased PCBP2 expression can activate the rodspecific exon in BSG.
